Trial Profile
A randomized, double-blind, placebo-controlled study to evaluate the escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression
- Focus Therapeutic Use
- 27 Nov 2015 New trial record